Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 18/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 18/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 18/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 18/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 18/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5542453 | 0.70 | SLC6A2 (0.47) | — | |
| SCHEMBL9532190 | 0.67 | CHRM2 (0.37) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL8516623 | 0.59 | CFTR (0.50) | — | |
| SCHEMBL1673372 | 0.55 | ALDH1A1 (0.40) | — | |
| SCHEMBL16857693 | 0.55 | ALDH1A1 (0.40) | — | |
| SCHEMBL1673336 | 0.55 | ALDH1A1 (0.40) | — | |
| SCHEMBL31678783 | 0.54 | CHRNA3 (0.36) | — | |
| Biphenyl SCHEMBL8637370 | 0.53 | ALDH1A1 (0.60) | — | |
| Biphenyl SCHEMBL6943550 | 0.52 | ALDH1A1 (0.69) | — | |
| Biphenyl SCHEMBL323849 | 0.52 | ALDH1A1 (0.69) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0556342-A1 | NEW 1-AZABICYCLOALKANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | GYOGYSZERKUTATO INTEZET K.V. (HU) | 1993-08-25 | — | — | EP | disclosed |
| WO-1992007854-A1 | NEW 1-AZABICYCLOALKANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | GYÓGYSZERKUTATÓ INTÉZET KV. (HU) | 1992-05-14 | — | — | WO | disclosed |